Related Experiment Video
Updated: Apr 20, 2026

Assessing the Putative Anticryptococcal Properties of Crude and Clarified Extracts from Mollusks
Published on: December 2, 2022
Wild mushroom extracts as inhibitors of bacterial biofilm formation
Maria José Alves1, Isabel C F R Ferreira2, Inês Lourenço3
1CBQF-Escola Superior de Biotecnologia, Universidade Católica Portuguesa Porto, Rua Dr. António Bernardino de Almeida, 4200-072 Porto, Portugal. ines.evamix@gmail.com.
Abstract:
Microorganisms can colonize a wide variety of medical devices, putting patients in risk for local and systemic infectious complications, including local-site infections, catheter-related bloodstream infections, and endocarditis. These microorganisms are able to grow adhered to almost every surface, forming architecturally complex communities termed biofilms. The use of natural products has been extremely successful in the discovery of new medicine, and mushrooms could be a source of natural antimicrobials. The present study reports the capacity of wild mushroom extracts to inhibit in vitro biofilm formation by multi-resistant bacteria. Four Gram-negative bacteria biofilm producers (Escherichia coli, Proteus mirabilis, Pseudomonas aeruginosa, and Acinetobacter baumannii) isolated from urine were used to verify the activity of Russula delica, Fistulina hepatica, Mycena rosea, Leucopaxilus giganteus, and Lepista nuda extracts. The results obtained showed that all tested mushroom extracts presented some extent of inhibition of biofilm production. Pseudomonas aeruginosa was the microorganism with the highest capacity of biofilm production, being also the most susceptible to the extracts inhibition capacity (equal or higher than 50%). Among the five tested extracts against E. coli, Leucopaxillus giganteus (47.8%) and Mycenas rosea (44.8%) presented the highest inhibition of biofilm formation. The extracts exhibiting the highest inhibitory effect upon P. mirabilis biofilm formation were Sarcodon imbricatus (45.4%) and Russula delica (53.1%). Acinetobacter baumannii was the microorganism with the lowest susceptibility to mushroom extracts inhibitory effect on biofilm production (highest inhibition-almost 29%, by Russula delica extract). This is a pioneer study since, as far as we know, there are no reports on the inhibition of biofilm production by the studied mushroom extracts and in particular against multi-resistant clinical isolates; nevertheless, other studies are required to elucidate the mechanism of action.
Insights
Wild mushroom extracts show potential in combating multi-resistant bacteria by inhibiting biofilm formation. This study highlights natural products as a promising source for novel antimicrobial strategies against challenging infections.
Area of Science:
- Microbiology
- Natural Product Chemistry
- Medical Mycology
Background:
- Microbial biofilms on medical devices pose significant risks for patient infections.
- Multi-resistant bacteria forming biofilms are a growing clinical concern.
- Natural products, including mushrooms, are explored for antimicrobial properties.
Purpose of the Study:
- To investigate the in vitro efficacy of wild mushroom extracts against biofilm formation by multi-resistant bacteria.
- To identify specific mushroom species with potent anti-biofilm activity.
Main Methods:
- Wild mushroom extracts (Russula delica, Fistulina hepatica, Mycena rosea, Leucopaxilus giganteus, Lepista nuda) were tested.
- In vitro biofilm inhibition assays were performed against four Gram-negative bacteria: Escherichia coli, Proteus mirabilis, Pseudomonas aeruginosa, and Acinetobacter baumannii.
- Inhibition percentages were quantified for each extract-bacterium combination.
Main Results:
- All tested mushroom extracts demonstrated some level of biofilm inhibition.
- Pseudomonas aeruginosa biofilms were most susceptible to inhibition (≥50%).
- Russula delica and Leucopaxillus giganteus extracts showed significant inhibition against E. coli and P. mirabilis, respectively.
Conclusions:
- Wild mushroom extracts possess anti-biofilm forming capacity against multi-resistant bacteria.
- This study is the first to report anti-biofilm activity of these specific mushroom extracts against clinical isolates.
- Further research is needed to determine the mechanisms of action for these natural antimicrobials.
More Related Videos
09:39A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries
Published on: December 27, 2016
08:20Systematic Approach to Identify Novel Antimicrobial and Antibiofilm Molecules from Plants' Extracts and Fractions to Prevent Dental Caries
Published on: March 31, 2021
Related Concept Videos
Biofilms
Biological Methods for Microbial Control
Antimicrobial Effectiveness
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...